Replies to post #781280 on NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

The meeting happened and the summary will be published sometime. And they will answer the asked question, "Was a brain cancer drug discussed". That answer will be either yes or no.

Wrong Ex,

Section 22 can only be relied upon in relation to the specific information requested, not for a general statement such as ‘we will publish the minutes of the May and June 2025 CHM meetings later, and you can see if they contain any information on a medicine for brain cancer,’ when the specific request was: ‘I would greatly appreciate it if you could confirm whether any discussions during the most recent May 2025 or June 2025 CHM meetings involved a medicine for the treatment of brain cancer.'

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176562225

ICO
Information Commissioner's Office

Information intended for future publication and research information (sections 22 and 22A)

The information that the public authority intends to be published must be the specific information the applicant has requested

.

https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiugbCt8omPAxW7QaQEHRDzCYcQFnoECBYQAQ&url=https%3A%2F%2Fico.org.uk%2Fmedia2%2Fmigrated%2F1172%2Finformation-intended-for-future-publication-and-research-information-sections-22-and-22a-foi.pdf&usg=AOvVaw2vEW8LOOsyQ2nb6RzdRLSj&opi=89978449